As all previous studies on the prognostic relevance of p27 expression in prostate cancer have analyzed comparatively small tumor sets with a maximum of 130 patients, it is possible that the analysis of large cohorts may provide clearer results. The gene discussed is CDKN1B; the disease is prostate cancer.